-
BUDGET IMPACT ANALYSIS OF SONPIRETIGENE ISTEPARVOVEC FOR RETINITIS PIGMENTOSA WITH SEVERE VISION LOSS
Mar 18, 2026, 21:38 PM -
REAL-WORLD DATA LARGE LANGUAGE MODEL ASSISTIVE SQL CODING SYSTEM
Mar 18, 2026, 21:38 PM -
EFFECTIVENESS OF COMMUNITY-BASED AND HOME-BASED HEALTH INTERVENTIONS FOR HEALTHY AGING IN LOW- AND MIDDLE-INCOME COUNTRIES: A SYSTEMATIC REVIEW OF RANDOMIZED TRIALS
Mar 18, 2026, 21:38 PM -
CAN A GENERATIVE PATIENT JOURNEY FOUNDATION MODEL ALLEVIATE THE BURDEN OF CANCER SCREENING?
Mar 18, 2026, 21:38 PM -
UNDERSTANDING HYPERTENSION IN YOUNG ADULTS: DIAGNOSIS TIMING, TIME WITHIN TARGET RANGE, AND BLOOD PRESSURE TRAJECTORIES
Mar 18, 2026, 21:38 PM -
ANALYSING THE FINANCIAL BURDEN AND ITS DETERMINANTS ON CANCER PATIENTS: A CROSS SECTIONAL STUDY FROM NORTH INDIA
Mar 18, 2026, 21:38 PM -
CROSS-VALIDATION OF AN EARLY COST-EFFECTIVENESS MODEL FOR SPECTRIS™ THERAPY USING THE ALZHEIMER’S DISEASE OPEN-SOURCE IPECAD MODEL FRAMEWORK
Mar 18, 2026, 21:38 PM -
HOW THE EU JOINT CLINICAL ASSESSMENT UNCERTAINTIES IMPACT US PHARMACEUTICAL MARKET ACCESS
Mar 18, 2026, 21:38 PM -
TWO-YEAR COST ANALYSIS OF RADICAL PROSTATECTOMY - INDEX PROCEDURES AND ADJUVANT THERAPIES
Mar 18, 2026, 21:38 PM -
WHICH PROVIDERS PRESCRIBE ANTIVIRALS FOR COVID-19 TREATMENT IN THE US?
Mar 18, 2026, 21:38 PM -
FROM SINGLE-ARM EVIDENCE TO HTA-READY SURVIVAL COMPARISONS: EXTENDING MULTILEVEL NETWORK META-REGRESSION TO DISCONNECTED NETWORKS FOR TIME-TO-EVENT OUTCOMES IN NEWLY DIAGNOSED MULTIPLE MYELOMA
Mar 18, 2026, 21:38 PM -
HEALTHCARE RESOURCE UTILIZATION AND COSTS IN JAPANESE PATIENTS WITH GENERALIZED MYASTHENIA GRAVIS INITIATING EFGARTIGIMOD: A REAL-WORLD RETROSPECTIVE ANALYSIS
Mar 18, 2026, 21:38 PM -
RACING TO MARKET: WHAT HAPPENS AFTER FDA EXPEDITED APPROVAL IN ORPHAN DRUGS?
Mar 18, 2026, 21:38 PM -
FROM REAL-WORLD DATA (RWD) TO DIGITAL TWINS: BUILDING MODELS FOR PATIENT-LEVEL COUNTERFACTUAL PREDICTION IN ONCOLOGY
Mar 18, 2026, 21:38 PM -
REPRESENTATIVENESS OF LINKED CLAIMS-EHR DATA: CLAIMS-ONLY VS CLAIMS+EHR POPULATIONS
Mar 18, 2026, 21:38 PM -
OFF-LABEL USE AND ADHERENCE TO GLP-1S AS ADJUNCT THERAPY IN TYPE 1 DIABETES: A COMPARATIVE ANALYSIS VERSUS METFORMIN
Mar 18, 2026, 21:38 PM -
ANTI-ISH VACCINATION: PATTERNS OF CHILDHOOD VACCINE UPTAKE IN THE FIRST 24 MONTHS IN CHILDREN VACCINATED OR NOT FOR MEASLES/MUMPS/RUBELLA
Mar 18, 2026, 21:38 PM -
ECONOMIC EVALUATION OF HORMONAL TREATMENT STRATEGIES FOR INFANTILE EPILEPTIC SPASMS SYNDROME IN INDIAN CHILDREN
Mar 18, 2026, 21:38 PM -
MACHINE LEARNING-BASED PREDICTION FOR NEPHROTOXICITY IN ONCOLOGY PATIENTS WITH CHEMOTHERAPY
Mar 18, 2026, 21:38 PM -
EFFECTIVENESS AND SAFETY OF PRASUGREL VERSUS TICAGRELOR AFTER PCI: A REAL-WORLD COHORT STUDY
Mar 18, 2026, 21:38 PM
